Sacks Natalie 4
4 · Zymeworks Inc. · Filed Dec 23, 2022
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Sacks Natalie
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-12-21+25,000→ 25,000 totalExercise: $8.75Exp: 2032-12-20→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Stock options vest on date of next annual general meeting following grant date of December 21, 2022.